STAT+: What an abandoned heart failure trial says about ‘breakthrough’ devices that don’t reach patients
An abandoned heart-failure trial offers a rare window into devices that the FDA deems "breakthrough" but never reach patients.
Read the full article on the original site.
Read Full Article